BofA reiterates McCormick stock rating on Unilever deal talks By Investing.com

Unilever and McCormick are reported to be in advanced talks to combine Unilever’s food business with McCormick in an all-stock deal potentially valued at ~$33B in equity vs McCormick’s $14.5B market cap; BofA sees the transaction likely as a Reverse Morris Trust and maintains a $80 price target on MKC. McCormick reported Q4 FY2025 EPS of $0.86 (vs $0.87 forecast) and revenue $1.85B (vs $1.84B), the stock is down ~31% over the past year and yields 3.55%; analysts (Stifel to $65 Hold, TD Cowen to $75 Buy) have trimmed targets citing higher costs and softer FY26 guidance.

Analysis

Combining two large branded food platforms would create immediate procurement and route-to-market scale, but meaningful margin capture typically takes 18–36 months and requires ~3–5% annual SG&A run‑rate elimination to move the needle. Expect realistic synergy capture in the $300–700m range over three years, offset by one‑time integration costs and working‑capital swings of $100–250m; that implies ~150–300bps potential EBIT margin uplift if execution is clean.

The competitive second‑order winners are private‑label processors and regional spice houses that could be squeezed out of consolidated retailer negotiations, while mid‑cap branded rivals may lose shelf prominence and face pricing pressure. Retailers will likely demand category discounts or promotional funding in exchange for combined SKU placement, transferring margin pressure back to the producer; this creates acquisition opportunities for adjacencies that are divested for regulatory or strategic reasons.

Key catalysts and risks are asymmetric: near‑term catalysts (days–months) include formal transaction filings, shareholder votes, and earnings updates that reframe accretion math; medium term (6–18 months) centers on regulator feedback and integration milestones. Tail risks include a broken deal (shares repriced to preoffer levels), forced divestitures that reduce projected synergies, and commodity/FX moves that widen the gap between pro‑forma forecasts and realized margins.

Market reaction will be dictated by clarity on shareholder mix and governance: if the combined float shifts materially toward the seller’s base, the market may assign a different multiple to the surviving management thesis. That creates a window for event‑driven strategies that hedge execution risk while targeting the re‑rating optionality over a 6–24 month horizon.

Key Decisions for Investors

• Event pair (6–12 months): Long MKC equity sized 1–2% NAV and short UL equity sized to match implied economic exposure (ratio hedge ~1.1x). Rationale: capture deal re‑rating/announcement upside while limiting single‑name risk if deal breaks; target asymmetric upside 20–40% vs limited funded downside ~10–15% if hedge ratio maintained.
• Options arbitrage (12–18 months): Buy a MKC long call spread (calendar or LEAP) and fund with selling a tight UL call spread at higher strikes. Goal: 2–3x payout if transaction completes/re‑rates MKC; max loss = premium paid (~fully defined) if deal collapses or re‑rating stalls.
• Hedge against integration/commodity risk (3–9 months): Buy put spread on UL (or purchase downside protection) sized at 0.5–1% NAV to protect against regulatory/divestiture-driven reprice; this caps downside from protracted integration issues while keeping neutral to modest upside if transaction succeeds.
• Opportunistic shorts (9–24 months): Monitor mid‑cap branded rivals (e.g., regional spice/seasoning names) for margin compression; consider shorting those with >30% exposure to North American grocery channels and weak private‑label defenses if combined entity extracts promotional concessions—target 12–18% return if retailer pass‑through accelerates.